Neurobiology of Addition Medicine Flashcards
mesolimbic DA pathway
projection from ventral segmental area (VTA, area A10) –> nucleus accumbens
corticolimbic pathway
projections from VTA –> prefrontal cortex
nigrostriatal pathway
projections from SN (area A9) –> dorsal striatum
How GABAergic projections to the mesolimbic DA system modulate DA release in addiction
GABA projections from NA go to ventral palladium and inhibit GABA cells, creates “inhibition of inhibition = excitation” effect
those VP GABAs usually inhibit DA in VTA,
so if inhibiting those ultimately releasing more DA –> excitation
How glutamatergic projections to the mesolimbic DA system modulate DA release in addiction
DA release from VTA to prefrontal cortex –> glutamate release from prefrontal cortex to VTA –> release more DA, EXCITATION
or
glutamate release from prefrontal cortex to NA –> GABA release from NA to VTA –> INHIBITION of DA release
nicotine
acts at ligand-gated ion channels that comprise VTA nicotinic ACh receptors
gate Na+ and allow selective permeation of Ca++
dominantly PRESYNAPTIC
cocaine
DA reuptake blocker from synapse by blockade of DAT
*cocaine reward is intact in DAT KO mice, poss due to reuptake blockade of DA at NEPI/5HT transporters
amphetamines
targets monoamine storage
competitive ligand to DAT and VMAT2 transporters (amphetamine builds up in vesicle, displaces DA to cytosol and extracellular space)
DAT starts to work in reverse and pump DA out of the cell and into synaptic cleft
- amphetamine also partial blocks normal DAT reuptake
opioids
- Activate metabotropic μ-opioid receptors on VTA cells. (G protein-linked receptor)
- Normal endogenous ligands: Endomorphin, Enkephalin, Dynorphin.
cannabinoids
- Activate metabotropic G protein-linked CB1 receptors on VTA cells primarily in CNS
- Also activate peripheral CB2 receptors
- Endogenous ligand: Anandamide
Barbiturates/Benzodiazepines
CNS depressants, sedatives, anxiolytics
- work at allosteric sites on GABA-gated chloride ion channels (Increase length of channel opening or frequency of firing)
- Increases inhibition of feedback from NA to VTA
- also blocks AMPA glutamate receptors –> CNS depression and relaxation, not euphoria (does not inc DA release).
EtOH effects on GABA receptors
- Positive allosteric modulator of GABA-A –> inhibition of GABAergic VTA neurons –> disinhibiting dopaminergic neurons in the VTA (euphoria)
- XS activity causes downregulation of GABA-A receptors
EtOH effects on NMDA receptors
- Negative modulator of NMDA receptors –> increased neuronal excitability (EtOH w/d symptoms)
- XS activity causes upregulation of NMDA receptors
EtOH w/d
aroused and hyper-aggressive
- downregulated GABA-A receptors
- upregulated of NMDA receptors
- increased neuronal excitability during acute w/d
- decreased DA release
Phencyclidine (PCP)
hallucinogen-dissociative anesthetic
blocks NMDA glutamate-gated ion channels and nAChr